In summary, this research clinically confirmed the tumour-promoting effect of BARX1 in OS at the cellular and molecular levels and demonstrated that BARX1 enhances OS cell proliferation and invasion by regulating the downstream effector molecule HSPA6, providing an innovative basic theory for studying OS. Here, HSPA6 is linked to neoplasm.